Detailed Information
Cited 3 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Phase 3, randomized, placebo-controlled study of stereotactic body radiotherapy (SBRT) with or without pembrolizumab in patients with unresected stage I or II non-small cell lung cancer (NSCLC): KEYNOTE-867.
- Authors
- Jabbour, SK[Jabbour, Salma K.]; Houghton, B[Houghton, Baerin]; Robinson, AG[Robinson, Andrew George]; Quantin, X[Quantin, Xavier]; Wehler, T[Wehler, Thomas]; Kowalski, D[Kowalski, Dariusz]; Ahn, MJ[Ahn, Myung-Ju]; Erman, M[Erman, Mustafa]; Giaccone, G[Giaccone, Giuseppe]; Borghaei, H[Borghaei, Hossein]; Xu, JMY[Xu, Jessica McLean Yan]; Souza, F[Souza, Fabricio]; Pall, G[Pall, Georg]
- Issue Date
- 1-Jun-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.